iCAD (ICAD) 10-Q 13 Nov 23 2023 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2023	Nov. 08, 2023
Document Information [Line Items]
Entity Central Index Key	0000749660
Entity Registrant Name	iCAD INC
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2023
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Document Transition Report	false
Entity File Number	001-09341
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	02-0377419
Entity Address, Address Line One	98 Spit Brook Road, Suite 100
Entity Address, City or Town	Nashua
Entity Address, State or Province	NH
Entity Address, Postal Zip Code	03062
City Area Code	603
Local Phone Number	882-5200
Title of 12(b) Security	Common Stock, $0.01 par value
Trading Symbol	ICAD
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		26,352,733

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 19,046	$ 21,313
Trade accounts receivable, net of allowance for credit losses of $230 and $100 as of September 30, 2023 and December 31, 2022, respectively	4,865	5,769
Inventory, net	992	2,054
Prepaid expenses and other current assets	1,603	1,571
Current assets held for sale	5,837	7,534
Total current assets	32,343	38,241
Property and equipment, net of accumulated depreciation of $991 and $851 as of September 30, 2023 and December 31, 2022, respectively	1,285	704
Operating lease assets	514	670
Other assets	47	19
Intangible assets, net of accumulated amortization of $8,459 and $8,372 as of September 30, 2023 and December 31, 2022, respectively	177	264
Goodwill	8,362	8,362
Deferred tax assets	104	116
Noncurrent assets held for sale	2,996	3,329
Total assets	45,828	51,705
Current liabilities:
Accounts payable	1,098	1,446
Accrued and other expenses	2,385	2,541
Less: current portion of lease liabilities	197	217
Deferred revenue—current portion	3,343	3,653
Current liabilities held for sale	4,389	5,595
Total current liabilities	11,412	13,452
Long-term lease liabilities	317	455
Deferred revenue, net of current	844	393
Deferred tax	6	6
Noncurrent liabilities held for sale	2,214	2,497
Total liabilities	14,793	16,803
Commitments and Contingencies (Note 12)
Stockholders’ equity:
Preferred stock, $0.01 par value: authorized 1,000,000 shares; none issued.	0	0
Common stock, $0.01 par value: authorized 60,000,000 shares; issued 26,440,464 and 25,446,407 as of September 30, 2023 and December 31, 2022, respectively; outstanding 26,254,633 and 25,260,576 as of September 30, 2023 and December 31, 2022, respectively.	264	254
Additional paid-in capital	305,924	302,899
Accumulated deficit	(273,738)	(266,836)
Treasury stock at cost, 185,831 shares as of both September 30, 2023 and December 31, 2022	(1,415)	(1,415)
Total stockholders’ equity	31,035	34,902
Total liabilities and stockholders’ equity	$ 45,828	$ 51,705

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Allowance for doubtful accounts on trade accounts receivable	$ 230	$ 100
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	991	851
Intangible assets, accumulated amortization	$ 8,459	$ 8,372
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, shares issued (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	60,000,000	60,000,000
Common stock, shares issued (in shares)	26,440,464	25,446,407
Common stock, shares outstanding (in shares)	26,254,633	25,260,576
Treasury Stock, Common, Shares (in shares)	185,831	185,831

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenue:
Revenue	$ 4,073,000	$ 4,359,000	$ 12,578,000	$ 15,167,000
Cost of revenue:
Cost of revenue	552,000	655,000	2,115,000	2,250,000
Gross profit	3,521,000	3,704,000	10,463,000	12,917,000
Operating expenses:
Engineering and product development	1,147,000	1,407,000	3,909,000	4,359,000
Marketing and sales	1,495,000	2,761,000	5,690,000	8,206,000
General and administrative	2,042,000	2,649,000	7,650,000	7,804,000
Amortization and depreciation	56,000	52,000	186,000	169,000
Total operating expenses	4,740,000	6,869,000	17,435,000	20,538,000
Loss from operations	(1,219,000)	(3,165,000)	(6,972,000)	(7,621,000)
Other income/ (expense):
Interest expense	0	(7,000)	(2,000)	(7,000)
Interest income	195,000	71,000	528,000	89,000
Other income (expense), net	(9,000)	(2,000)	(8,000)	(45,000)
Other income (expense), net	186,000	62,000	518,000	37,000
Loss before provision for income taxes	(1,033,000)	(3,103,000)	(6,454,000)	(7,584,000)
Provision for income taxes	(4,000)	0	(13,000)	0
Loss from continuing operations	(1,037,000)	(3,103,000)	(6,467,000)	(7,584,000)
Loss from discontinued operations, net of tax	(337,000)	(795,000)	(435,000)	(2,977,000)
Net loss and comprehensive loss	$ (1,374,000)	$ (3,898,000)	$ (6,902,000)	$ (10,561,000)
Net loss per share:
Loss from continuing operations, basic and diluted (in dollars per share)	$ (0.04)	$ (0.12)	$ (0.25)	$ (0.3)
Loss from discontinued operations, basic and diluted (in dollars per share)	(0.01)	(0.03)	(0.02)	(0.12)
Net loss per share (in dollars per share)	$ (0.05)	$ (0.15)	$ (0.27)	$ (0.42)
Weighted average number of shares used in computing loss per share:
Basic and diluted (in shares)	25,597	25,204	25,374	25,183
Product [Member]
Revenue:
Revenue	$ 2,198,000	$ 2,536,000	$ 6,961,000	$ 9,866,000
Cost of revenue:
Cost of revenue	263,000	348,000	1,099,000	1,253,000
Service and Supplies [Member]
Revenue:
Revenue	1,875,000	1,823,000	5,617,000	5,301,000
Cost of revenue:
Cost of revenue	267,000	280,000	951,000	916,000
Amortization and Depreciation [Member]
Cost of revenue:
Cost of revenue	$ 22,000	$ 27,000	$ 65,000	$ 81,000

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock, Common [Member]	Total
Balance (in shares) at Dec. 31, 2021	25,326,086
Balance at Dec. 31, 2021	$ 253	$ 300,859	$ (253,180)	$ (1,415)	$ 46,517
Issuance of common stock pursuant to stock option plans (in shares)	73,833
Issuance of common stock pursuant to stock option plans	$ 1	205	0	0	206
Stock-based compensation	0	1,369	0	0	1,369
Net loss	$ 0	0	(10,561)	0	(10,561)
Issuance of common stock pursuant Employee Stock Purchase Plans (in shares)	28,141
Issuance of common stock pursuant Employee Stock Purchase Plans	$ 0	127	0	0	127
Issuance of common stock relative to vesting of restricted stock (in shares)	875
Issuance of common stock relative to vesting of restricted stock	$ 0	0	0	0	0
Balance (in shares) at Sep. 30, 2022	25,428,935
Balance at Sep. 30, 2022	$ 254	302,560	(263,741)	(1,415)	37,658
Balance (in shares) at Jun. 30, 2022	25,373,858
Balance at Jun. 30, 2022	$ 254	301,994	(259,843)	(1,415)	40,990
Issuance of common stock pursuant to stock option plans (in shares)	45,000
Issuance of common stock pursuant to stock option plans	$ 0	127	0	0	127
Stock-based compensation	0	405	0	0	405
Net loss	$ 0	0	(3,898)	0	(3,898)
Issuance of common stock pursuant Employee Stock Purchase Plans (in shares)	10,077
Issuance of common stock pursuant Employee Stock Purchase Plans	$ 0	34	0	0	34
Balance (in shares) at Sep. 30, 2022	25,428,935
Balance at Sep. 30, 2022	$ 254	302,560	(263,741)	(1,415)	37,658
Balance (in shares) at Dec. 31, 2022	25,446,407
Balance at Dec. 31, 2022	$ 254	302,899	(266,836)	(1,415)	$ 34,902
Issuance of common stock pursuant to stock option plans (in shares)	35,809				35,809
Issuance of common stock pursuant to stock option plans	$ 0	80			$ 80
Issuance of common stock, net of issuance costs of $336 (in shares)	958,248
Issuance of common stock, net of issuance costs of $336	$ 10	1,831			1,841
Stock-based compensation	0	1,114	0	0	1,114
Net loss	$ 0	0	(6,902)	0	(6,902)
Balance (in shares) at Sep. 30, 2023	26,440,464
Balance at Sep. 30, 2023	$ 264	305,924	(273,738)	(1,415)	31,035
Balance (in shares) at Jun. 30, 2023	25,446,407
Balance at Jun. 30, 2023	$ 254	303,699	(272,364)	(1,415)	30,174
Issuance of common stock pursuant to stock option plans (in shares)	35,809
Issuance of common stock pursuant to stock option plans	$ 0	80			80
Issuance of common stock, net of issuance costs of $336 (in shares)	958,248
Issuance of common stock, net of issuance costs of $336	$ 10	1,831			1,841
Stock-based compensation	0	314	0	0	314
Net loss	$ 0	0	(1,374)	0	(1,374)
Balance (in shares) at Sep. 30, 2023	26,440,464
Balance at Sep. 30, 2023	$ 264	$ 305,924	$ (273,738)	$ (1,415)	$ 31,035

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) (Parentheticals) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2023
Issuance costs	$ 336	$ 336

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flow from operating activities:
Net loss	$ (6,902)	$ (10,561)
Adjustments to reconcile net loss to net cash used for operating activities:
Amortization	142	158
Depreciation	202	246
Non-cash lease expense	409	549
Bad debt provision	189	510
Stock-based compensation	1,114	1,369
Deferred tax	12	0
Changes in operating assets and liabilities:
Accounts receivable	1,903	(91)
Inventory	1,472	(1,459)
Prepaid and other assets	38	7
Accounts payable	(509)	(351)
Accrued and other expenses	(1,022)	(98)
Lease liabilities	(420)	(602)
Deferred revenue	(141)	663
Total adjustments	3,389	901
Net cash used for operating activities	(3,513)	(9,660)
Cash flow from investing activities:
Additions to patents, technology and other	0	(10)
Additions to property and equipment	(487)	(355)
Capitalization of internal-use software development costs	(188)	0
Net cash used for investing activities	(675)	(365)
Cash flow from financing activities:
Proceeds from option exercises pursuant to stock option plans	80	206
Proceeds from issuances of common stock, net of issuance costs	1,841	0
Proceeds from issuance of common stock pursuant to Employee Stock Purchase Plans	0	127
Net cash provided by financing activities	1,921	333
Decrease in cash and cash equivalents	(2,267)	(9,692)
Cash and cash equivalents, beginning of period	21,313	34,282
Cash and cash equivalents, end of period	19,046	24,590
Supplemental disclosure of cash flow information:
Interest paid	0	7
Amendment to right-of-use assets obtained in exchange for operating lease liabilities	$ 0	$ 2,434

Note 1 - Basis of Presentation

Note 1 - Basis of Presentation and Significant Accounting Policies	9 Months Ended
	Sep. 30, 2023
Notes to Financial Statements
Significant Accounting Policies [Text Block]	Note 1 Basis of Presentation and Significant Accounting Policies Basis of Presentation The accompanying condensed consolidated financial statements of iCAD, Inc. and its subsidiaries (together “iCAD” or the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”), which requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses during the reporting period and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates. It is reasonably possible that changes may September 30, 2023 three nine September 30, 2023 2022 nine September 30, 2023 2022 three nine September 30, 2023 2022 As discussed in Note 2, October 23, 2023. September 30, 2023 December 31, 2022, Although the Company believes that the disclosures made in these interim financial statements are adequate to make the information presented not 10 December 31, 2022 March 31, 2023. three nine September 30, 2023 not may December 31, 2023, Principles of Consolidation and Business Segments The condensed consolidated financial statements include the accounts of iCAD, Inc. and its wholly owned subsidiaries: Xoft, Inc., Xoft Solutions, LLC, iCAD France, LLC and iCAD Italy, LLC. All material inter-company transactions and balances have been eliminated in consolidation. The Company previously reported the results of two segments: Cancer Detection (“Detection”) and Cancer Therapy (“Therapy”). The Detection segment consists of advanced image analysis and workflow products for the detection of cancer. The Therapy segment consists of radiation therapy (“Xoft”, “Axxent”) products for the treatment of certain cancers. As discussed in Note 2, October 23, 2023. September 30, 2023 December 31, 2022, Assets and Liabilities Held for Sale The Company classifies its assets and liabilities as held for sale when management commits to a plan to sell the assets, the assets are ready for immediate sale in their present condition, an active program to locate buyers has been initiated, the sale of the assets is probable and expected to be completed within one Assets and liabilities held for sale in the Condensed Consolidated Balance Sheets pertain to applicable assets and liabilities of the Xoft business. See Note 2 Risk and Uncertainty On March 12, 2020, 19 19, June 30, 2023, 19 In late February 2022, October 2023, may may may not three nine September 30, 2023, Recently Adopted Accounting Pronouncements In June 2016, 2016 13, 326 2016 13 2016 13 November 2019, 2016 13 December 15, 2022. 2016 13 2016 13 January 1, 2023. twelve 2016 13 not

Note 2 - Discontinued Operation

Note 2 - Discontinued Operations	9 Months Ended
	Sep. 30, 2023
Notes to Financial Statements
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]	Note 2 Discontinued Operations On October 22, 2023, no November 6, 2023, The closing of the Transaction occurred simultaneously with the execution of the Purchase Agreement. In connection with the Transaction, the parties entered into a transition services agreement pursuant to which the Company will provide certain migration and transition services to facilitate an orderly transition of the operation of the Business to the Buyers during the 5 The Purchase Agreement contains certain representations, warranties, covenants and indemnification provisions, including for breaches of covenants and for losses resulting from the Company’s liabilities specifically excluded from the Transaction. The Business, which had previously been presented as a separate reporting segment, meets the criteria for being reported as a discontinued operation and has been segregated from continuing operations. The following table summarizes the results from discontinued operations: Three months ended Nine months ended September 30, September 30, 2023 2022 2023 2022 Revenue $ 1,414 $ 1,998 $ 4,551 $ 6,287 Total cost of sales (916 ) (1,328 ) (2,516 ) (4,029 ) Gross profit $ 498 $ 670 $ 2,036 $ 2,258 Total operating expenses (835 ) (1,465 ) (2,471 ) (5,235 ) Provision for income taxes — — — — Loss from discontinued operations, net of tax $ (337 ) $ (795 ) $ (435 ) $ (2,977 ) Total operating expenses presented in the table above exclude amounts that had previously been allocated to the Business for certain shared marketing expenses. The previously allocated amounts were less than $0.1 million and $0.2 million for the three September 30, 2023 2022, nine September 30, 2023 2022, The following table summarizes the assets and liabilities held for sale in the Company's Consolidated Balance Sheets: September 30, 2023 December 31, 2022 Assets Accounts receivable, net of allowance for credit losses $ 1,941 $ 3,129 Inventories, net 2,925 3,335 Prepaid expenses and other current assets 971 1,070 Total current assets held for sale $ 5,837 $ 7,534 Net property and equipment $ 345 $ 370 Operating lease assets 2,438 2,691 Other assets 213 268 Total noncurrent assets held for sale $ 2,996 $ 3,329 Liabilities Accounts payable $ 358 $ 527 Accrued and other expenses 1,358 2,140 Lease payable - current portion 452 365 Deferred revenue - current portion 2,221 2,563 Total current liabilities held for sale $ 4,389 $ 5,595 Lease payable, net of current 2,004 2,348 Deferred revenue, net of current 210 149 Noncurrent liabilities held for sale $ 2,214 $ 2,497 The Business is included in the Company's Condensed Consolidated Statements of Cash Flows for the nine September 30, 2023. nine September 30, 2023 nine September 30, 2022

Note 3 - Fair Value Measurement

Note 3 - Fair Value Measurements	9 Months Ended
	Sep. 30, 2023
Notes to Financial Statements
Fair Value Disclosures [Text Block]	Note 3 Fair Value Measurements The Company follows the provisions of FASB ASC Topic 820, 820” three first two • Level 1 • Level 2 1 not • Level 3 no The assigned level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Money market funds included in cash and cash equivalents in the accompanying consolidated balance sheet are considered a Level 1 The following table sets forth the Company’s assets which are measured at fair value on a recurring basis by level within the fair value hierarchy: Fair Value Measurements as of September 30, 2023 Level 1 Level 2 Level 3 Total Assets Money market accounts $ 15,342 $ — $ — $ 15,342 Total Assets $ 15,342 $ — $ — $ 15,342 Fair Value Measurements as of December 31, 2022 Level 1 Level 2 Level 3 Total Assets Money market accounts $ 15,067 $ — $ — $ 15,067 Total Assets $ 15,067 $ — $ — $ 15,067 There were no Level 2 3 September 30, 2023 December 31, 2022

Note 4 - Revenue

Note 4 - Revenue	9 Months Ended
	Sep. 30, 2023
Notes to Financial Statements
Revenue from Contract with Customer [Text Block]	Note 4 Revenue Recognition Revenue is recognized when a customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration which the Company expects to be entitled to receive in exchange for these goods or services and excludes any sales incentives or taxes collected from customers which are subsequently remitted to government authorities. Disaggregation of Revenue The following tables presents the Company’s revenues disaggregated by major good or service line, timing of revenue recognition, and sales channel, reconciled to its reportable segments. Three months ended September 30, 2023 Major Goods/Service Lines Products $ 2,198 Service contracts 1,875 $ 4,073 Timing of Revenue Recognition Goods transferred at a point in time $ 1,834 Services transferred over time 2,239 $ 4,073 Sales Channels Direct sales force 2,825 OEM partners 1,248 $ 4,073 Nine months ended September 30, 2023 Major Goods/Service Lines Products $ 6,961 Service contracts 5,617 $ 12,578 Timing of Revenue Recognition Goods transferred at a point in time $ 5,779 Services transferred over time 6,799 $ 12,578 Sales Channels Direct sales force $ 8,287 OEM partners 4,291 $ 12,578 Three months ended September 30, 2022 Major Goods/Service Lines Products $ 2,536 Service contracts 1,823 $ 4,359 Timing of Revenue Recognition Goods transferred at a point in time $ 2,510 Services transferred over time 1,849 $ 4,359 Sales Channels Direct sales force $ 2,947 OEM partners 1,412 $ 4,359 Nine months ended September 30, 2022 Major Goods/Service Lines Products $ 9,866 Service contracts 5,301 $ 15,167 Timing of Revenue Recognition Goods transferred at a point in time $ 9,844 Services transferred over time 5,323 $ 15,167 Sales Channels Direct sales force $ 9,347 OEM partners 5,820 $ 15,167 Products. Service As discussed in Note 2, October 23, 2023. Contract Balances Contract liabilities are a component of deferred revenue, current contract assets are a component of prepaid and other assets and non-current contract assets are a component of other assets. The following table provides information about receivables, current and non-current contract assets, and contract liabilities from contracts with customers. Contract balances Balance at Balance at Balance at September 30, 2023 December 31, 2022 December 31, 2021 Receivables, which are included in ‘Trade accounts receivable’ $ 4,865 $ 5,769 $ 4,263 Current contract assets, which are included in “Prepaid and other assets” $ 1,194 $ 748 $ 1,895 Non-current contract assets, which are included in “other assets” $ 43 $ 15 $ 844 Contract liabilities, which are included in “Deferred revenue” $ 4,187 $ 4,046 $ 3,621 Timing of revenue recognition may The Company records net contract assets or contract liabilities on a contract-by-contract basis. The Company records a contract asset for unbilled revenue when the Company’s performance is in excess of amounts billed or billable. The Company classifies the net contract asset as either a current or non-current based on the expected timing of the Company’s right to bill under the terms of the contract. The current contract asset balance primarily relates to the net unbilled revenue balances with two one one one Changes in deferred revenue from contracts with customers were as follows: Nine Months Ended September 30, 2023 Balance at beginning of period $ 4,046 Deferral of revenue 5,810 Recognition of deferred revenue (5,669 ) Balance at end of period $ 4,187 As of September 30, 2023 two three

Note 4 - Net Loss Per Common Sh

Note 4 - Net Loss Per Common Share	9 Months Ended
	Sep. 30, 2023
Notes to Financial Statements
Earnings Per Share [Text Block]	Note 5 Net Loss per Common Share The Company’s basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the period. A summary of the Company’s calculation of loss per share is as follows (in 000s, Three Months Ended Nine Months Ended September 30, September 30, 2023 2022 2023 2022 Loss from continuing operations $ (1,037 ) $ (3,103 ) $ (6,467 ) $ (7,584 ) Loss from discontinued operations (337 ) (795 ) (435 ) (2,977 ) Net loss $ (1,374 ) $ (3,898 ) $ (6,902 ) $ (10,561 ) Shares used in the calculation of basic and diluted net loss per share 25,597 25,204 25,374 25,183 Loss per share from continuing operations - basic and diluted $ (0.04 ) $ (0.12 ) $ (0.25 ) $ (0.30 ) Loss per share from discontinued operations - basic and diluted (0.01 ) (0.03 ) (0.02 ) (0.12 ) Net loss per share - basic and diluted $ (0.05 ) $ (0.15 ) $ (0.27 ) $ (0.42 ) The shares of the Company’s common stock issuable upon the exercise of stock options and vesting of restricted stock that were excluded from the calculation of diluted net loss per share because their effect would have been antidilutive are as follows: September 30, 2023 2022 Stock options 3,209,591 2,624,154 Total 3,209,591 2,624,154

Note 6 - Inventories

Note 6 - Inventories	9 Months Ended
	Sep. 30, 2023
Notes to Financial Statements
Inventory Disclosure [Text Block]	Note 6 Inventories The Company values its inventory at the lower of cost or net realizable value. Cost includes materials, labor, and manufacturing overhead and is determined using the first first September 30, 2023 December 31, 2022 September 30, 2023 December 31, 2022 Raw materials $ 971 $ 1,910 Work in process 16 134 Finished goods 50 55 Inventory gross 1,037 2,099 Inventory reserve (45 ) (45 ) Inventory net $ 992 $ 2,054

Note 7 - Goodwill

Note 7 - Goodwill	9 Months Ended
	Sep. 30, 2023
Notes to Financial Statements
Goodwill Disclosure [Text Block]	Note 7 Goodwill The Company tests goodwill for impairment on an annual basis and between annual tests if events and circumstances indicate it is more likely than not • significant underperformance relative to historical or projected future operating results; • significant changes in the manner or use of the assets or the strategy for the Company’s overall business; • significant negative industry or economic trends; • significant decline in the Company’s stock price for a sustained period; and • a decline in the Company’s market capitalization below net book value. The Company considered indicators of impairment, and there were no no three September 30, 2023 2022

Note 8 - Long-lived Assets

Note 8 - Long-lived Assets	9 Months Ended
	Sep. 30, 2023
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	Note 8 Long-lived Assets The Company assesses long-lived assets for impairment if events and circumstances indicate it is more likely than not There is no may not • A significant decrease in the market price of a long-lived asset (or asset group); • A significant adverse change in the extent or manner in which a long-lived asset (or asset group) is being used or in its physical condition; • A significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset (or asset group), including an adverse action or assessment by a regulator; • An accumulation of costs significantly in excess of the amount originally expected for the acquisition or construction of a long-lived asset (or asset group); and • A current operating period, or cash flow loss combined with a history of operating or cash flow losses or a projection or forecast that demonstrates continuing losses associated with the use of a long-lived asset (or asset group). The Company determined there were no September 30, 2023

Note 9 - Lease Commitments

Note 9 - Lease Commitments	9 Months Ended
	Sep. 30, 2023
Notes to Financial Statements
Lessee, Operating Leases [Text Block]	Note 9 Lease Commitments In accordance with ASC Topic 842 842" At lease inception, the Company recognizes a lease liability equal to the present value of the remaining lease payments, and a right of use asset equal to the lease liability, subject to certain adjustments, such as for lease incentives. In determining the present value of the lease payments, the Company calculates an incremental borrowing rate, which is determined by estimating the Company’s applicable, fully collateralized borrowing rate, with adjustment as appropriate for lease term. The lease term at the lease commencement date is determined based on the non-cancellable period for which the Company has the right to use the underlying asset, together with any periods covered by an extension option if the Company is reasonably certain to exercise that option. Assumptions made by the Company at the commencement date of each lease are re-evaluated upon occurrence of certain events, including a lease modification. A lease modification results in a separate contract when the modification grants the lessee an additional right of use not Right-of-use assets and obligations for leases with an initial term of 12 not not third not 606 ASC 842 three nine September 30, 2023 Certain of the Company’s leases include variable lease costs to reimburse the lessor for real estate tax and insurance expenses, and certain non-lease components that transfer a distinct service to the Company, such as common area maintenance services. The Company has elected to separate the accounting for lease components and non-lease components for real estate and equipment leases. Components of Leases: The Company has leases for office space and office equipment. The leases expire at various dates through 2028. Three Months Ended Nine Months Ended Lease Cost Classification September 30, 2023 September 30, 2023 Operating lease cost - Right of Use Asset Operating expenses $ 63 $ 186 Other information related to leases was as follows: Three Months Nine Months Ended September 30, 2023 Ended September 30, 2023 Cash paid from operating cash flows for operating leases $ 65 $ 193 As of September 30, 2023 Weighted-average remaining lease term of operating leases (years) 2.0 % Weighted-average discount rate for operating leases 6.8 % Maturity of the Company’s lease liabilities as of September 30, 2023 2023 $ 64 2024 219 2025 204 2026 85 Total lease payments 572 Less: effects of discounting (58 ) Total lease liabilities 514 Less: current portion of lease liabilities 197 Long-term lease liabilities $ 317

Note 10 - Stockholders Equity

Note 10 - Stockholders Equity	9 Months Ended
	Sep. 30, 2023
Notes to Financial Statements
Equity [Text Block]	Note 10 Stockholders Equity Stock-Based Compensation The Company granted options to purchase 562,774 and 1,103,916 shares of the Company’s stock during the three nine September 30, 2023 first nine 2023 The Company’s stock-based compensation expense, including options and restricted stock by category is as follows: Three Months Ended Nine Months Ended September 30, September 30, 2023 2022 2023 2022 Cost of revenue $ 1 $ 1 $ 3 $ 2 Engineering and product development 56 37 188 182 Marketing and sales 75 133 268 441 General and administrative 171 234 655 744 $ 303 $ 405 $ 1,114 $ 1,369 During the three March 31, 2023, five four 2023. one As of September 30, 2023 Options granted under the Company’s stock incentive plans were valued utilizing the Black-Scholes model using the following assumptions and had the following fair values: Three Months Ended Nine Months Ended September 30, September 30, 2023 2022 2023 2022 Average risk-free interest rate 4.94 % n/a* 4.30 % 1.90 % Expected dividend yield None None None None Expected life (in years) 2.5 n/a* 2.9 3.5 Expected volatility 84.3% - 134.4% n/a* 72.7% to 134.4% 66.3% to 70.5% Weighted average exercise price $ 2.70 n/a* $ 1.82 $ 5.22 Weighted average fair value $ 1.34 n/a* $ 0.97 $ 2.46 * The Company granted no options during the three September 30, 2022 The Company’s 2023 2022 zero not The Company did not three September 30, 2023 2022 one first one A summary of stock option activity for all stock option plans for the period ended September 30, 2023 Number of Weighted Average Intrinsic Options Exercise Price Value Outstanding as of December 31, 2022 2,610,992 $ 7.54 $ — Granted 1,179,868 $ 1.82 Exercised (35,809 ) $ 2.24 $ 2 Cancelled (544,127 ) $ 4.98 Outstanding as of September 30, 2023 3,210,924 $ 5.61 $ 969 Options Exercisable as of December 31, 2022 1,619,855 $ 6.47 $ — Options Exercisable as of September 30, 2023 2,042,460 $ 7.13 $ 47 Employee Stock Purchase Plan In December 2019, 2019 January 1, 2020. may October 2022, October 1, 2022 December 31, 2022 not Prior to the Company's suspension of the ESPP, any eligible employee could enroll as of the beginning of a respective quarterly accumulation period. Employees who participated in the ESPP were able to purchase shares by authorizing payroll deductions of up to 15% of their base compensation during an accumulation period. Unless the participating employee withdrew from participation, accumulated payroll deductions were used to purchase shares of common stock on the last business day of the accumulation period (the “Purchase Date”) at a price equal to 85% of the lower of the fair market value on (i) the Purchase Date or (ii) the first no 20 5% not The Company issued 8,683 and 18,064 shares under the ESPP in the three nine September 30, 2022 three nine September 30, 2022

Note 11 - Income Taxes

Note 11 - Income Taxes	9 Months Ended
	Sep. 30, 2023
Notes to Financial Statements
Income Tax Disclosure [Text Block]	Note 11 Income Taxes The determination of the annual effective tax rate is based upon a number of significant estimates and judgments, including the estimated annual pretax income in each tax jurisdiction in which the Company operates and the development of tax planning strategies during the year. As such, there can be significant volatility in interim tax provisions. Income tax expense was approximately $4,000 and approximately $13,000 for the three nine September 30, 2023 , three nine September 30, 2023 2022 2023 2022

Note 12 - Commitments and Conti

Note 12 - Commitments and Contingencies	9 Months Ended
	Sep. 30, 2023
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	Note 12 Commitments and Contingencies Other Commitments The Company is obligated to pay approximately $1.1 million for firm purchase obligations to suppliers for future product and service deliverables and $0.4 million for minimum royalty obligations. Litigation The Company may no not ASC 450

Note 13 - Restructuring

Note 13 - Restructuring	9 Months Ended
	Sep. 30, 2023
Notes to Financial Statements
Restructuring and Related Activities Disclosure [Text Block]	Note 13 Restructuring On March 20, 2023, 2, October 23, 2023. The Company has incurred charges of $0.2 million related to the RIF, all of which were recognized during the nine September 30, 2023 one not may 2023. The Company's accrual for restructuring charges for the nine September 30, 2023 Balance as of January 1, 2023 $ — Charges 178 Cash payments (160 ) Balance as of September 30, 2023 $ 18

Note 14 - Issuances of Common S

Note 14 - Issuances of Common Stock	9 Months Ended
	Sep. 30, 2023
Notes to Financial Statements
Issuances of Common Stock [Text Block]	Note 14 Issuances of Common Stock As previously disclosed, on August 11, 2023, may 415 three September 30, 2023, September 30, 2023,

Significant Accounting Policies

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of Presentation The accompanying condensed consolidated financial statements of iCAD, Inc. and its subsidiaries (together “iCAD” or the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”), which requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses during the reporting period and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates. It is reasonably possible that changes may September 30, 2023 three nine September 30, 2023 2022 nine September 30, 2023 2022 three nine September 30, 2023 2022 As discussed in Note 2, October 23, 2023. September 30, 2023 December 31, 2022, Although the Company believes that the disclosures made in these interim financial statements are adequate to make the information presented not 10 December 31, 2022 March 31, 2023. three nine September 30, 2023 not may December 31, 2023,
Principles of Consolidation and Business Segments [Policy Text Block]	Principles of Consolidation and Business Segments The condensed consolidated financial statements include the accounts of iCAD, Inc. and its wholly owned subsidiaries: Xoft, Inc., Xoft Solutions, LLC, iCAD France, LLC and iCAD Italy, LLC. All material inter-company transactions and balances have been eliminated in consolidation. The Company previously reported the results of two segments: Cancer Detection (“Detection”) and Cancer Therapy (“Therapy”). The Detection segment consists of advanced image analysis and workflow products for the detection of cancer. The Therapy segment consists of radiation therapy (“Xoft”, “Axxent”) products for the treatment of certain cancers. As discussed in Note 2, October 23, 2023. September 30, 2023 December 31, 2022,
Discontinued Operations, Policy [Policy Text Block]	Assets and Liabilities Held for Sale The Company classifies its assets and liabilities as held for sale when management commits to a plan to sell the assets, the assets are ready for immediate sale in their present condition, an active program to locate buyers has been initiated, the sale of the assets is probable and expected to be completed within one Assets and liabilities held for sale in the Condensed Consolidated Balance Sheets pertain to applicable assets and liabilities of the Xoft business. See Note 2
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Risk and Uncertainty On March 12, 2020, 19 19, June 30, 2023, 19 In late February 2022, October 2023, may may may not three nine September 30, 2023,
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Adopted Accounting Pronouncements In June 2016, 2016 13, 326 2016 13 2016 13 November 2019, 2016 13 December 15, 2022. 2016 13 2016 13 January 1, 2023. twelve 2016 13 not

Note 2 - Discontinued Operati_2

Note 2 - Discontinued Operations (Tables)	9 Months Ended
	Sep. 30, 2023
Notes Tables
Disposal Groups, Including Discontinued Operations [Table Text Block]	Three months ended Nine months ended September 30, September 30, 2023 2022 2023 2022 Revenue $ 1,414 $ 1,998 $ 4,551 $ 6,287 Total cost of sales (916 ) (1,328 ) (2,516 ) (4,029 ) Gross profit $ 498 $ 670 $ 2,036 $ 2,258 Total operating expenses (835 ) (1,465 ) (2,471 ) (5,235 ) Provision for income taxes — — — — Loss from discontinued operations, net of tax $ (337 ) $ (795 ) $ (435 ) $ (2,977 ) September 30, 2023 December 31, 2022 Assets Accounts receivable, net of allowance for credit losses $ 1,941 $ 3,129 Inventories, net 2,925 3,335 Prepaid expenses and other current assets 971 1,070 Total current assets held for sale $ 5,837 $ 7,534 Net property and equipment $ 345 $ 370 Operating lease assets 2,438 2,691 Other assets 213 268 Total noncurrent assets held for sale $ 2,996 $ 3,329 Liabilities Accounts payable $ 358 $ 527 Accrued and other expenses 1,358 2,140 Lease payable - current portion 452 365 Deferred revenue - current portion 2,221 2,563 Total current liabilities held for sale $ 4,389 $ 5,595 Lease payable, net of current 2,004 2,348 Deferred revenue, net of current 210 149 Noncurrent liabilities held for sale $ 2,214 $ 2,497

Note 3 - Fair Value Measureme_2

Note 3 - Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2023
Notes Tables
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	Level 1 Level 2 Level 3 Total Assets Money market accounts $ 15,342 $ — $ — $ 15,342 Total Assets $ 15,342 $ — $ — $ 15,342 Level 1 Level 2 Level 3 Total Assets Money market accounts $ 15,067 $ — $ — $ 15,067 Total Assets $ 15,067 $ — $ — $ 15,067

Note 4 - Revenue (Tables)

Note 4 - Revenue (Tables)	9 Months Ended
	Sep. 30, 2023
Notes Tables
Disaggregation of Revenue [Table Text Block]	Three months ended September 30, 2023 Major Goods/Service Lines Products $ 2,198 Service contracts 1,875 $ 4,073 Timing of Revenue Recognition Goods transferred at a point in time $ 1,834 Services transferred over time 2,239 $ 4,073 Sales Channels Direct sales force 2,825 OEM partners 1,248 $ 4,073 Nine months ended September 30, 2023 Major Goods/Service Lines Products $ 6,961 Service contracts 5,617 $ 12,578 Timing of Revenue Recognition Goods transferred at a point in time $ 5,779 Services transferred over time 6,799 $ 12,578 Sales Channels Direct sales force $ 8,287 OEM partners 4,291 $ 12,578 Three months ended September 30, 2022 Major Goods/Service Lines Products $ 2,536 Service contracts 1,823 $ 4,359 Timing of Revenue Recognition Goods transferred at a point in time $ 2,510 Services transferred over time 1,849 $ 4,359 Sales Channels Direct sales force $ 2,947 OEM partners 1,412 $ 4,359 Nine months ended September 30, 2022 Major Goods/Service Lines Products $ 9,866 Service contracts 5,301 $ 15,167 Timing of Revenue Recognition Goods transferred at a point in time $ 9,844 Services transferred over time 5,323 $ 15,167 Sales Channels Direct sales force $ 9,347 OEM partners 5,820 $ 15,167
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]	Balance at Balance at Balance at September 30, 2023 December 31, 2022 December 31, 2021 Receivables, which are included in ‘Trade accounts receivable’ $ 4,865 $ 5,769 $ 4,263 Current contract assets, which are included in “Prepaid and other assets” $ 1,194 $ 748 $ 1,895 Non-current contract assets, which are included in “other assets” $ 43 $ 15 $ 844 Contract liabilities, which are included in “Deferred revenue” $ 4,187 $ 4,046 $ 3,621
Deferred Revenue, by Arrangement, Disclosure [Table Text Block]	Nine Months Ended September 30, 2023 Balance at beginning of period $ 4,046 Deferral of revenue 5,810 Recognition of deferred revenue (5,669 ) Balance at end of period $ 4,187

Note 4 - Net Loss Per Common _2

Note 4 - Net Loss Per Common Share (Tables)	9 Months Ended
	Sep. 30, 2023
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended Nine Months Ended September 30, September 30, 2023 2022 2023 2022 Loss from continuing operations $ (1,037 ) $ (3,103 ) $ (6,467 ) $ (7,584 ) Loss from discontinued operations (337 ) (795 ) (435 ) (2,977 ) Net loss $ (1,374 ) $ (3,898 ) $ (6,902 ) $ (10,561 ) Shares used in the calculation of basic and diluted net loss per share 25,597 25,204 25,374 25,183 Loss per share from continuing operations - basic and diluted $ (0.04 ) $ (0.12 ) $ (0.25 ) $ (0.30 ) Loss per share from discontinued operations - basic and diluted (0.01 ) (0.03 ) (0.02 ) (0.12 ) Net loss per share - basic and diluted $ (0.05 ) $ (0.15 ) $ (0.27 ) $ (0.42 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	September 30, 2023 2022 Stock options 3,209,591 2,624,154 Total 3,209,591 2,624,154

Note 6 - Inventories (Tables)

Note 6 - Inventories (Tables)	9 Months Ended
	Sep. 30, 2023
Notes Tables
Schedule of Inventory, Current [Table Text Block]	September 30, 2023 December 31, 2022 Raw materials $ 971 $ 1,910 Work in process 16 134 Finished goods 50 55 Inventory gross 1,037 2,099 Inventory reserve (45 ) (45 ) Inventory net $ 992 $ 2,054

Note 9 - Lease Commitments (Tab

Note 9 - Lease Commitments (Tables)	9 Months Ended
	Sep. 30, 2023
Notes Tables
Lease, Cost [Table Text Block]	Three Months Ended Nine Months Ended Lease Cost Classification September 30, 2023 September 30, 2023 Operating lease cost - Right of Use Asset Operating expenses $ 63 $ 186 Three Months Nine Months Ended September 30, 2023 Ended September 30, 2023 Cash paid from operating cash flows for operating leases $ 65 $ 193 As of September 30, 2023 Weighted-average remaining lease term of operating leases (years) 2.0 % Weighted-average discount rate for operating leases 6.8 %
Financing Lease and Lessee Operating Lease Liability Maturity [Table Text Block]	2023 $ 64 2024 219 2025 204 2026 85 Total lease payments 572 Less: effects of discounting (58 ) Total lease liabilities 514 Less: current portion of lease liabilities 197 Long-term lease liabilities $ 317

Note 10 - Stockholders Equity (

Note 10 - Stockholders Equity (Tables)	9 Months Ended
	Sep. 30, 2023
Notes Tables
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	Three Months Ended Nine Months Ended September 30, September 30, 2023 2022 2023 2022 Cost of revenue $ 1 $ 1 $ 3 $ 2 Engineering and product development 56 37 188 182 Marketing and sales 75 133 268 441 General and administrative 171 234 655 744 $ 303 $ 405 $ 1,114 $ 1,369
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Three Months Ended Nine Months Ended September 30, September 30, 2023 2022 2023 2022 Average risk-free interest rate 4.94 % n/a* 4.30 % 1.90 % Expected dividend yield None None None None Expected life (in years) 2.5 n/a* 2.9 3.5 Expected volatility 84.3% - 134.4% n/a* 72.7% to 134.4% 66.3% to 70.5% Weighted average exercise price $ 2.70 n/a* $ 1.82 $ 5.22 Weighted average fair value $ 1.34 n/a* $ 0.97 $ 2.46
Share-Based Payment Arrangement, Option, Activity [Table Text Block]	Number of Weighted Average Intrinsic Options Exercise Price Value Outstanding as of December 31, 2022 2,610,992 $ 7.54 $ — Granted 1,179,868 $ 1.82 Exercised (35,809 ) $ 2.24 $ 2 Cancelled (544,127 ) $ 4.98 Outstanding as of September 30, 2023 3,210,924 $ 5.61 $ 969 Options Exercisable as of December 31, 2022 1,619,855 $ 6.47 $ — Options Exercisable as of September 30, 2023 2,042,460 $ 7.13 $ 47

Note 13 - Restructuring (Tables

Note 13 - Restructuring (Tables)	9 Months Ended
	Sep. 30, 2023
Notes Tables
Restructuring and Related Costs [Table Text Block]	Balance as of January 1, 2023 $ — Charges 178 Cash payments (160 ) Balance as of September 30, 2023 $ 18

Note 1 - Basis of Presentatio_2

Note 1 - Basis of Presentation and Significant Accounting Policies (Details Textual)	3 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2023
Number of Operating Segments		2
Revenue Benchmark [Member] | Geographic Concentration Risk [Member] | Non-US [Member]
Concentration Risk, Percentage	16%	14%

Note 2 - Discontinued Operati_3

Note 2 - Discontinued Operations (Details Textual) - Disposal Group, Held-for-Sale, Not Discontinued Operations [Member] - Xoft Solutions, LLC [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Oct. 22, 2023
Disposal Group, Including Discontinued Operation, Operating Expense	$ 835	$ 1,465	$ 2,471	$ 5,235
Net Cash Provided by (Used in) Discontinued Operations			100	(3,000)
Shared Marketing Expense [Member]
Disposal Group, Including Discontinued Operation, Operating Expense		$ 200	$ 300	$ 500
Shared Marketing Expense [Member] | Maximum [Member]
Disposal Group, Including Discontinued Operation, Operating Expense	$ 100
Subsequent Event [Member]
Disposal Group, Including Discontinued Operation, Consideration					$ 5,760

Note 2 - Discontinued Operati_4

Note 2 - Discontinued Operations - Summary of Discontinued Operations (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Loss from discontinued operations, net of tax	$ (337)	$ (795)	$ (435)	$ (2,977)
Total current assets held for sale	5,837		5,837		$ 7,534
Total noncurrent assets held for sale	2,996		2,996		3,329
Total current liabilities held for sale	4,389		4,389		5,595
Noncurrent liabilities held for sale	2,214		2,214		2,497
Disposal Group, Held-for-Sale, Not Discontinued Operations [Member] | Xoft Solutions, LLC [Member]
Revenue	1,414	1,998	4,551	6,287
Total cost of sales	(916)	(1,328)	(2,516)	(4,029)
Gross profit	498	670	2,036	2,258
Total operating expenses	(835)	(1,465)	(2,471)	(5,235)
Provision for income taxes	0	0	0	0
Loss from discontinued operations, net of tax	(337)	$ (795)	(435)	$ (2,977)
Accounts receivable, net of allowance for credit losses	1,941		1,941		3,129
Inventories, net	2,925		2,925		3,335
Prepaid expenses and other current assets	971		971		1,070
Total current assets held for sale	5,837		5,837		7,534
Net property and equipment	345		345		370
Operating lease assets	2,438		2,438		2,691
Other assets	213		213		268
Total noncurrent assets held for sale	2,996		2,996		3,329
Accounts payable	358		358		527
Accrued and other expenses	1,358		1,358		2,140
Lease payable - current portion	452		452		365
Deferred revenue - current portion	2,221		2,221		2,563
Total current liabilities held for sale	4,389		4,389		5,595
Lease payable, net of current	2,004		2,004		2,348
Deferred revenue, net of current	210		210		149
Noncurrent liabilities held for sale	$ 2,214		$ 2,214		$ 2,497

Note 3 - Fair Value Measureme_3

Note 3 - Fair Value Measurements (Details Textual) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Fair Value, Inputs, Level 2 [Member]
Assets, Fair Value Disclosure, Total	$ 0	$ 0
Fair Value, Inputs, Level 3 [Member]
Assets, Fair Value Disclosure, Total	$ 0	$ 0

Note 3 - Fair Value Measureme_4

Note 3 - Fair Value Measurements - Assets and Liabilities which are Measured at Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Fair Value, Inputs, Level 2 [Member]
Assets, fair value	$ 0	$ 0
Fair Value, Inputs, Level 3 [Member]
Assets, fair value	0	0
Fair Value, Recurring [Member]
Assets, fair value	15,342	15,067
Fair Value, Recurring [Member] | Money Market Funds [Member]
Assets, fair value	15,342	15,067
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Assets, fair value	15,342	15,067
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member] | Money Market Funds [Member]
Assets, fair value	15,342	15,067
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Assets, fair value	0	0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member] | Money Market Funds [Member]
Assets, fair value	0	0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Assets, fair value	0	0
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 [Member] | Money Market Funds [Member]
Assets, fair value	$ 0	$ 0

Note 4 - Revenue 1 (Details Tex

Note 4 - Revenue 1 (Details Textual) $ in Millions	9 Months Ended
	Sep. 30, 2023 USD ($)
Revenue, Remaining Performance Obligation, Amount	$ 4.2
Minimum [Member]
Service Contracts, Term (Month)	12 months
Maximum [Member]
Service Contracts, Term (Month)	48 months

Note 4 - Revenue 2 (Details Tex

Note 4 - Revenue 2 (Details Textual) $ in Millions	Sep. 30, 2023 USD ($)
Revenue, Remaining Performance Obligation, Amount	$ 4.2
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Revenue, Remaining Performance Obligation, Amount	$ 3.3
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period (Month)	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01 | Minimum [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period (Month)	2 years
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01 | Maximum [Member]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period (Month)	3 years

Note 4 - Revenue - Revenues Dis

Note 4 - Revenue - Revenues Disaggregated by Major Good or Service Line, Timing of Revenue Recognition, and Sales Channel, Reconciled to Our Reportable Segments (Details) - Detection [Member] - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenue from contracts with customers	$ 4,073	$ 4,359	$ 12,578	$ 15,167
Direct Sales Force [Member]
Revenue from contracts with customers	2,825	2,947	8,287	9,347
OEM Partners [Member]
Revenue from contracts with customers	1,248	1,412	4,291	5,820
Transferred at Point in Time [Member]
Revenue from contracts with customers	1,834	2,510	5,779	9,844
Transferred over Time [Member]
Revenue from contracts with customers	2,239	1,849	6,799	5,323
Product [Member]
Revenue from contracts with customers	2,198	2,536	6,961	9,866
Service Contracts [Member]
Revenue from contracts with customers	$ 1,875	$ 1,823	$ 5,617	$ 5,301

Note 4 - Revenue - Summary of R

Note 4 - Revenue - Summary of Receivables, Contract Assets and Contract Liabilities from Contracts with Customers (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Receivables, which are included in ‘Trade accounts receivable’	$ 4,865	$ 5,769	$ 4,263
Current contract assets, which are included in “Prepaid and other assets”	1,194	748	1,895
Non-current contract assets, which are included in “other assets”	43	15	844
Contract liabilities, which are included in “Deferred revenue”	$ 4,187	$ 4,046	$ 3,621

Note 4 - Revenue - Summary of C

Note 4 - Revenue - Summary of Changes in Deferred Revenue from Contracts with Customers (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2023 USD ($)
Balance at beginning of period	$ 4,046
Deferral of revenue	5,810
Recognition of deferred revenue	(5,669)
Balance at end of period	$ 4,187

Note 4 - Net Loss Per Common _3

Note 4 - Net Loss Per Common Share - Calculation of Net Loss Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Loss from continuing operations	$ (1,037)	$ (3,103)	$ (6,467)	$ (7,584)
Loss from discontinued operations, net of tax	(337)	(795)	(435)	(2,977)
Net loss and comprehensive loss	$ (1,374)	$ (3,898)	$ (6,902)	$ (10,561)
Basic and diluted (in shares)	25,597	25,204	25,374	25,183
Loss from continuing operations, basic and diluted (in dollars per share)	$ (0.04)	$ (0.12)	$ (0.25)	$ (0.3)
Loss from discontinued operations, basic and diluted (in dollars per share)	(0.01)	(0.03)	(0.02)	(0.12)
Net loss per share (in dollars per share)	$ (0.05)	$ (0.15)	$ (0.27)	$ (0.42)

Note 4 - Net Loss Per Common _4

Note 4 - Net Loss Per Common Share - Schedule of Anti-dilutive Shares Excluded From Computation of Diluted Net Loss Per Share (Details) - shares	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Antidilutive securities (in shares)	3,209,591	2,624,154
Share-Based Payment Arrangement, Option [Member]
Antidilutive securities (in shares)	3,209,591	2,624,154

Note 6 - Inventories (Details T

Note 6 - Inventories (Details Textual) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Inventory Valuation Reserves	$ 45,000	$ 45,000

Note 6 - Inventory - Schedule o

Note 6 - Inventory - Schedule of Current Inventory (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Raw materials	$ 971,000	$ 1,910,000
Work in process	16,000	134,000
Finished goods	50,000	55,000
Inventory gross	1,037,000	2,099,000
Inventory reserve	(45,000)	(45,000)
Inventory net	$ 992,000	$ 2,054,000

Note 7 - Goodwill (Details Text

Note 7 - Goodwill (Details Textual) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Goodwill, Impairment Loss	$ 0	$ 0

Note 9 - Lease Commitments (Det

Note 9 - Lease Commitments (Details Textual) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2023
Operating Lease, Impairment Loss	$ 0	$ 0

Note 9 - Lease Commitments - Sc

Note 9 - Lease Commitments - Schedule of Components of Lease Expense (Details) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2023 USD ($)	Sep. 30, 2023 USD ($)
Operating lease cost - Right of Use Asset	$ 63	$ 186
Cash paid from operating cash flows for operating leases	$ 65	$ 193
Weighted-average remaining lease term of operating leases (years) (Year)	2 years	2 years
Weighted-average discount rate for operating leases	6.80%	6.80%

Note 9 - Lease Commitments - Su

Note 9 - Lease Commitments - Summary of Detained Information of Lease Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
2023	$ 64
2024	219
2025	204
2026	85
Total lease payments	572
Less: effects of discounting	(58)
Total lease liabilities	514
Less: current portion of lease liabilities	197	$ 217
Long-term lease liabilities	$ 317	$ 455

Note 10 - Stockholders Equity_2

Note 10 - Stockholders Equity (Details Textual)	3 Months Ended			9 Months Ended		12 Months Ended
	Sep. 30, 2023 USD ($) shares	Mar. 31, 2023 USD ($)	Sep. 30, 2022 USD ($) shares	Sep. 30, 2023 USD ($) shares	Sep. 30, 2022 USD ($) shares	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross (in shares) | shares	562,774		1,103,916	1,179,868
Share-Based Payment Arrangement, Expense	$ 303,000		$ 405,000	$ 1,114,000	$ 1,369,000
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount	$ 1,200,000			$ 1,200,000
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)				1 year 8 months 12 days
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures (in shares) | shares			0
Dividends, Common Stock				$ 0
ESPP [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares) | shares	950,000			950,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate	15%			15%
Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Offering Date				85%
Share Based Compensation Arrangement By Share Based Payment Award, Maximum Amount of Shares Per Employee				$ 25,000,000
Stock Issued During Period, Shares, Employee Stock Purchase Plans (in shares) | shares			8,683		18,064
Employee Benefits and Share-Based Compensation			$ 12,000		$ 22,000
Four Grantees [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term (Year)		5 years
Modified Stock Options [Member]
Share-Based Payment Arrangement, Expense		$ 230,000
Modified Stock Options [Member] | One Grantee [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Day)		24 months				90 days
Restricted Stock [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period (in shares) | shares	0		0
Restricted Stock [Member] | Share-Based Payment Arrangement, Tranche One [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Day)				1 year
Restricted Stock [Member] | Share-Based Payment Arrangement, Tranche Two [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period (Day)				1 year
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting, Number of Installments	3			3

Note 10 - Stockholders Equity -

Note 10 - Stockholders Equity - Stock-Based Compensation Expense Including Options and Restricted Stock by Category (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Allocated share-based compensation expense	$ 303	$ 405	$ 1,114	$ 1,369
Cost of Sales [Member]
Allocated share-based compensation expense	1	1	3	2
Engineering and Product Development [Member]
Allocated share-based compensation expense	56	37	188	182
Selling and Marketing Expense [Member]
Allocated share-based compensation expense	75	133	268	441
General and Administrative Expense [Member]
Allocated share-based compensation expense	$ 171	$ 234	$ 655	$ 744

Note 10 - Stockholders Equity_3

Note 10 - Stockholders Equity - Options Granted under Company's Stock Incentive Plans, Valuation Assumptions and Fair Values (Details) - $ / shares	3 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2023	Sep. 30, 2022
Average risk-free interest rate	4.94%	4.30%	1.90%
Expected dividend yield	0%	0%	0%
Expected life (in years) (Year)	2 years 6 months	2 years 10 months 24 days	3 years 6 months
Granted, weighted average exercise price (in dollars per share)	$ 2.7	$ 1.82	$ 5.22
Weighted average fair value (in dollars per share)	$ 1.34	$ 0.97	$ 2.46
Minimum [Member]
Expected volatility	84.30%	72.70%	66.30%
Maximum [Member]
Expected volatility	134.40%	134.40%	70.50%

Note 10 - Stockholders Equity_4

Note 10 - Stockholders Equity - Summary of Stock Option Activity for Stock Option Plan (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Outstanding, shares (in shares)			2,610,992
Outstanding, weighted average exercise price (in dollars per share)			$ 7.54
Outstanding, aggregate intrinsic value	$ 969		$ 969		$ 0
Granted, shares (in shares)	562,774	1,103,916	1,179,868
Granted, weighted average exercise price (in dollars per share)	$ 2.7		$ 1.82	$ 5.22
Granted, aggregate intrinsic value
Exercised, shares (in shares)			(35,809)
Exercised, weighted average exercise price (in dollars per share)			$ 2.24
Exercised, aggregate intrinsic value			$ 2
Cancelled, shares (in shares)			(544,127)
Cancelled, weighted average exercise price (in dollars per share)			$ 4.98
Outstanding, shares (in shares)	3,210,924		3,210,924
Outstanding, weighted average exercise price (in dollars per share)	$ 5.61		$ 5.61
Options Exercisable, shares (in shares)	2,042,460		2,042,460		1,619,855
Options Exercisable, weighted average exercise price (in dollars per share)	$ 7.13		$ 7.13		$ 6.47
Options Exercisable, aggregate intrinsic value	$ 47		$ 47		$ 0

Note 11 - Income Taxes (Details

Note 11 - Income Taxes (Details Textual) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Tax Expense (Benefit)	$ 4,000	$ 0	$ 13,000	$ 0
Effective Income Tax Rate Reconciliation, Percent	1%	1%	1%	1%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent			21%	21%

Note 12 - Commitments and Con_2

Note 12 - Commitments and Contingencies (Details Textual) $ in Millions	Sep. 30, 2023 USD ($)
Purchase Obligation	$ 1.1
Royalty Obligations [Member]
Other Commitment	$ 0.4

Note 13 - Restructuring (Detail

Note 13 - Restructuring (Details Textual) - USD ($) $ in Thousands		9 Months Ended
	Mar. 20, 2023	Sep. 30, 2023
Restructuring and Related Cost, Number of Positions Eliminated, Period Percent	28%
Restructuring and Related Cost, Number of Positions Eliminated	23
Restructuring and Related Cost, Expected Cost Remaining		$ 0
Employee Severance [Member]
Restructuring Costs		$ 200
Xoft Inc [Member]
Restructuring and Related Cost, Number of Positions Eliminated, Period Percent	50%
Restructuring and Related Cost, Number of Positions Eliminated	12

Note 13 - Restructuring - Accru

Note 13 - Restructuring - Accrual for Restructuring Charges (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2023 USD ($)
Beginning Balance	$ 0
Charges	178
Cash payments	(160)
Ending Balance	$ 18

Note 14 - Issuances of Common_2

Note 14 - Issuances of Common Stock (Details Textual) - USD ($)	1 Months Ended	3 Months Ended	9 Months Ended
	Nov. 13, 2023	Sep. 30, 2023	Sep. 30, 2023	Sep. 30, 2022	Aug. 11, 2023
Proceeds from Issuance of Common Stock			$ 1,841,000	$ 0
At-the-market Sales Agreement [Member]
Equity Offering, Maximum Amount					$ 25,000,000
Stock Issued During Period, Shares, New Issues (in shares)		958,248
Shares Issued, Price Per Share (in dollars per share)		$ 2.26	$ 2.26
Proceeds from Issuance of Common Stock		$ 1,800,000
At-the-market Sales Agreement [Member] | Subsequent Event [Member]
Stock Issued During Period, Shares, New Issues (in shares)	37,266
Shares Issued, Price Per Share (in dollars per share)	$ 1.46
Proceeds from Issuance of Common Stock	$ 53,000